HEPAJUVE Trademark

Trademark Overview

On Thursday, January 10, 2019, a trademark application was filed for HEPAJUVE with the United States Patent and Trademark Office. The USPTO has given the HEPAJUVE trademark a serial number of 88256994. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by Intercept Pharmaceuticals, Inc.. The HEPAJUVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis
hepajuve

General Information

Serial Number88256994
Word MarkHEPAJUVE
Filing DateThursday, January 10, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 31, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, March 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 14, 2022SOU EXTENSION 5 GRANTED
Thursday, January 6, 2022SOU EXTENSION 5 FILED
Friday, January 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 6, 2022TEAS EXTENSION RECEIVED
Thursday, July 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 27, 2021SOU EXTENSION 4 GRANTED
Tuesday, April 27, 2021SOU EXTENSION 4 FILED
Tuesday, April 27, 2021TEAS EXTENSION RECEIVED
Friday, January 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2021SOU EXTENSION 3 GRANTED
Wednesday, January 13, 2021SOU EXTENSION 3 FILED
Wednesday, January 13, 2021TEAS EXTENSION RECEIVED
Thursday, March 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 24, 2020SOU EXTENSION 2 GRANTED
Tuesday, March 24, 2020SOU EXTENSION 2 FILED
Tuesday, March 24, 2020TEAS EXTENSION RECEIVED
Saturday, January 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2020SOU EXTENSION 1 GRANTED
Thursday, January 9, 2020SOU EXTENSION 1 FILED
Thursday, January 9, 2020TEAS EXTENSION RECEIVED
Monday, November 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 19, 2019ASSIGNED TO LIE
Tuesday, April 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 2, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, April 2, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 2, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, April 2, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Thursday, January 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 14, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

hepajuve liver pharmaceutical preparations nonalcoholic treating steatohepatitis fatty cirrhosis fibrosis disease